MINISO Group Holding Ltd vs Twist Bioscience Corp — how do they compare? MINISO Group Holding Ltd trades at $9.6 (market cap $2.65B), while Twist Bioscience Corp trades at $159.78 (market cap $10.08B). The key difference: Twist Bioscience Corp is far larger — about 3.8× MINISO Group Holding Ltd's market cap, and MINISO Group Holding Ltd pays a 7.34% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold MINISO Group Holding Ltd for 25 Days and Twist Bioscience Corp for 27 Days on average.
| MNSO | TWST | |
|---|---|---|
Market Cap | $2.65B | $10.08B |
Volume | 747,763 | 4,229,037 |
Sector | Consumer Cyclical | Health |
52-Week High | $22.75 | $205.00 |
52-Week Low | $8.60 | $25.45 |
Typical Hold Time | 25 Days | 27 Days |
Enterprise Value | $3.52B | $10.01B |
Dividend Yield | 7.34% | — |
Signals from Pluang's Aura AI — not financial advice
MNSO trades at $9.07, up 1.45% on the day, amid mixed technical signals and recent earnings volatility. The stock exhibits a bearish technical trend with neutral oscillators, while fundamentals show solid revenue growth to $23.5B in 2026 and a net income margin of 5.35%. Recent news highlights insider buying by the CFO and analyst optimism despite some earnings misses.
The outlook is cautiously optimistic given attractive valuations like a P/E of 14.76 and 60% analyst buy ratings, but risks include overseas margin pressure and inconsistent quarterly EPS performance. The stock's investment case hinges on execution of operational improvements and sustained domestic growth.
TWST trades at $152.05, down 2.31% today, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported Q2 2026 EPS of -$0.56, missing expectations, continuing a trend of losses despite revenue growth to $376.57M in 2025. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, driving investor optimism.
Outlook remains speculative with high valuation multiples (P/S 21.5, P/B 22.62) and persistent losses, but analyst consensus is bullish (73% buy ratings) with a $145.20 price target. Key risks include cash burn, competitive pressures, and reliance on AI-driven growth catalysts for profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →